HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chilton, H. M. Articles by Ekstrand, K. Search for Related Content PubMed PubMed Citation Articles by Chilton, H. M. Articles by Ekstrand, K.

Use of a Paramagnetic Substance, Colloidal Manganese Sulfide, as an NMR Contrast Material in Rats

Bowman Gray School of Medicine, and Wake Forest University, Winston-Salem, North Carolina

Correspondence: For reprints contact: Henry M. Chilton, Pharm D, Dept. of Radiology (Nuclear Medicine), Bowman Gray School of Medicine, 300 S. Hawthorne Rd., Winston-Salem, NC 27103.

ABSTRACT

Paramagnetic pharmaceuticals (magnetopharmaceuticals) that are suitably distributed into specific organ systems or diseased sites might be clinically useful for tissue contrast enhancement in nuclear magnetic resonance images. To determine whether an insoluble magnetopharmaceutical might be useful in such service, we investigated the effect of a colloidal preparation of manganese sulfide (MnSC) upon liver and lung spin-lattice relaxation times (T₁) in rats following intravenous administration. NMR tissue sample measurements were made at 24 MHz, and showed that after McSC treatment, liver T₁ values—and to a lesser extent lung T₁ values—were depressed below control values. Liver manganese content (as determined by flame atomic absorption spectrophotometry) increased in proportion to the dose of MnSC, and the reciprocal of the liver T₁ values also increased in proportion to the dose of McSC.

This article has been cited by other articles:

				J. A. Clanton Magnetic Resonance Imaging Contrast Agents and the Nuclear Pharmacist Journal of Pharmacy Practice, January 1, 1989; 2(3): 191 - 195. [Abstract] [PDF]